NCT01492205已完成不适用
A Doctor and Nurse Survey on Using NovoLet® Within the Hospital Practice in Indonesia
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 203
- 试验地点
- 1
- 主要终点
- Overall acceptance of the NovoLet® system among healthcare professionals (nurses and doctors)
研究概览
简要总结
This study is conducted in Asia. The aim of this study is to evaluate the overall acceptance of healthcare professionals (nurses and doctors) to the NovoLet® system used in a hospital environment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 1 diabetes
- •Type 2 diabetes
- •Likely to be hospitalised and require insulin therapy
排除标准
- 未提供
研究组 & 干预措施
Human insulin
干预措施: insulin human (Drug)
结局指标
主要结局
Overall acceptance of the NovoLet® system among healthcare professionals (nurses and doctors)
次要结局
- Time taken for the healthcare professionals (nurses and doctors) to teach the patient
- Incidence of adverse drug reactions
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in JapanCongenital Bleeding DisorderGlanzmann's DiseaseNCT01876745Novo Nordisk A/S4
已完成
不适用
Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes MellitusDiabetes Mellitus, Type 2Delivery SystemsDiabetesDiabetes Mellitus, Type 1NCT00806858Novo Nordisk A/S526
已完成
不适用
NovoLet® Surveillance Study on Using Human Insulin System in IndonesiaDiabetes Mellitus, Type 1DiabetesDiabetes Mellitus, Type 2NCT01492153Novo Nordisk A/S1,981
已完成
不适用
Observational Study With Mixtard® 30 NovoLet® to Assess Patient SatisfactionDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT01492218Novo Nordisk A/S1,330
已完成
不适用
Observational Study of NovoNorm® in Subjects With DiabetesDiabetesDiabetes Mellitus, Type 2NCT01498913Novo Nordisk A/S5,841